Antibodies (2)

Tremelimumab

Reference: HY-P9918

€0.00 (tax incl.)

Tremelimumab (Ticilimumab) is a fully humanized monoclonal antibody specific for cytotoxic T-lymphocyte antigen-4 (CTLA-4) and can be used for metastatic melanoma research.

Adalimumab (anti-TNF-α)

Reference: HY-P9908A

€0.00 (tax incl.)

Adalimumab (anti-TNF-α) is a human monoclonal IgG1 antibody targeting tumour necrosis factor α (TNF-α).

Labetuzumab

Reference: HY-P99160

€0.00 (tax incl.)

Labetuzumab is a humanised anti-carcinoembryonic antigen (CEA) monoclonal antibody that inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy.

Iscalimab

Reference: HY-P99670

€0.00 (tax incl.)

Iscalimab (CFZ-533) is a non-depleting IGg1 monoclonal antibody targeting CD40 (KD: 0.3 nM). Iscalimab can be used for research of Graves' hyperthyroidism and autoimmune diseases.

Lerdelimumab

Reference: HY-P99695

€0.00 (tax incl.)

Lerdelimumab (CAT-152) is an IgG4 human anti-TGF-β2 recombinant monoclonal antibody. Lerdelimumab can be used as an anti-scarring agent for glaucoma research.

Ziltivekimab (COR-001) is a human anti-IL-6 monoclonal antibody that is effective in reducing serum CRP. Ziltivekimab has anti-inflammatory activity and may be used in studies of chronic systemic inflammation and...

Pivekimab

Reference: HY-P99234

€0.00 (tax incl.)

Pivekimab is a human IgG1 monoclonal antibody targeting interleukin 3 (IL-3) and CD123. Pivekimab can be used in the study of blastocytic plasmacytoid dendritic cell tumor (BPDCN).

Grisnilimab setaritox

Reference: HY-P99651

€0.00 (tax incl.)

Grisnilimab setaritox (WT1-RTA), is an antihuman T cell antibody (anti-CD7) conjugating with ricin A chain (RTA). RTA is a 30-kDa peptide capable of rapidly in activating ribosomal 60S subunits. Grisnilimab setaritox...

Gatralimab

Reference: HY-P99635

€0.00 (tax incl.)

Gatralimab (GZ-402668) is an IgG1 anti-CD52 monoclonal antibody.

Oleclumab

Reference: HY-P99039

€0.00 (tax incl.)

Oleclumab (MEDI9447) is a human IgG1λ anti-CD73 monoclonal antibody that inhibits CD73 function. Oleclumab has an anti-tumor activity.

Parsatuzumab

Reference: HY-P99215

€0.00 (tax incl.)

Parsatuzumab (Anti-EGFL7; RG 7414) is a humanized monoclonal antibody, acts as an immunomodulator and binds to EGFL7. Parsatuzumab selectively blocks the interaction between EGFL7 and endothelial cells, potentially...

Nimotuzumab

Reference: HY-P9968

€0.00 (tax incl.)

Nimotuzumab is a humanized IgG1 monoclonal antibody targeting EGFR with a KD of 0.21 nM. Nimotuzumab is directed against the extracellular domain of the EGFR blocking the binding to its ligands. Nimotuzumab, a strong...

Domagrozumab

Reference: HY-P99857

€0.00 (tax incl.)

Domagrozumab is an anti-myostatin humanized monoclonal antibody with a KD value of 2.6 pM for human myostatin. Domagrozumab induces muscle anabolic activity. Domagrozumab can be used in research of duchenne muscular...

Zolbetuximab

Reference: HY-P99058

€0.00 (tax incl.)

Zolbetuximab (IMAB362) is a monoclonal antibody targeting Claudin-18.2. Zolbetuximab mediates specific killing of Claudin-18.2-positive cells through immune effector mechanisms. Zolbetuximab can be used for the...

Human IgG4 kappa, Isotype Control

Reference: HY-P99003

€0.00 (tax incl.)

Human IgG4 kappa, Isotype Control, a human monoclonal antibody, is an isotype control for human IgG4κ antibody.

Vesencumab

Reference: HY-P99386

€0.00 (tax incl.)

Vesencumab (MNRP-1685A) is IG1 antibody against neuropilin-1 (NRP-1). Vesencumab binds to NRP-1 and prevents the subsequent coupling of NRP-1 to VEGFR-2. Vesencumab has anti-angiogenic and anti-neoplastic activities....

Burosumab

Reference: HY-P9939

€0.00 (tax incl.)

Burosumab is a human fibroblast growth factor 23 (FGF23) neutralizing antibody that can be used for the research of X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia.

Citatuzumab bogatox

Reference: HY-P99282

€0.00 (tax incl.)

Citatuzumab bogatox (VB6-845) is recombinant immunotoxin that composed of Fab fragment of humanized antibody targeting EpCAM and a modified cytotoxin bouganin. Citatuzumab bogatox binds to and selectively induces...

Utomilumab

Reference: HY-P99056

€0.00 (tax incl.)

Utomilumab (PF 05082566) is a fully human IgG2 mAb agonist of the T-cell costimulatory receptor 4-1BB/CD137. Utomilumab can be used for the research of relapsed/refractory follicular lymphoma (FL) and other CD20+...

Emactuzumab

Reference: HY-P99245

€0.00 (tax incl.)

Emactuzumab(RG 7155) is a specific monoclonal antibody that inhibits colonystimulating factor 1 receptor (CSF1R) activation. Emactuzumab has high affinity for CSF-1R with Ki value of 0.2 nM to blocks CSF-1R...

Sacituzumab

Reference: HY-P99045

€0.00 (tax incl.)

Sacituzumab is a humanized IgG1 monoclonal antibody for anti-trophoblast cell-surface antigen 2 (anti-Trop-2). Sacituzumab has the potential for metastatic triple-negative breast cancer research.

Abagovomab

Reference: HY-P99276

€0.00 (tax incl.)

Abagovomab (Anti-Human CA-125 Recombinant Antibody) is a murine monoclonal anti-idiotypic antibody, against the tumor-associated antigen, CA-125. Abagovomab is generated by a mouse hybridoma, can imitate the human...

Nirsevimab

Reference: HY-P99756

€0.00 (tax incl.)

Nirsevimab (MEDI8897) is a recombinant human respiratory syncytial virus (RSV) monoclonal antibody with modified Fc region, which can prolong its half-life. Nirsevimab has an affinity for RSV-B with an Kd value of 1.5...

Tildrakizumab

Reference: HY-P99256

€0.00 (tax incl.)

Tildrakizumab (SCH 900222) is a humanized anti-IL-23 (p19 subunit) monoclonal antibody. IL-23 is a critical cytokine to maintain the Th17 cell phenotype. Tildrakizumab has high-affinity for single-chain IL-23 (Kd: 136...

Eptinezumab

Reference: HY-P99017

€0.00 (tax incl.)

Eptinezumab is a human monoclonal antibody. Eptinezumab binds to calcitonin gene-related peptide (CGRP) and blocks its binding to the receptor. Eptinezumab can be used for the prevention of migraine in adults.

Teplizumab

Reference: HY-P99222

€0.00 (tax incl.)

Teplizumab (MGA-031) is a Fc receptor non-binding anti-human CD3 monoclonal antibody. Teplizumab reduces the loss of beta-cell function. Teplizumab can be used in the research of type 1 diabetes.

Farletuzumab

Reference: HY-P99153

€0.00 (tax incl.)

Farletuzumab (MORAb-003) is a potent folate receptor-alpha (FRα) inhibitor. Farletuzumab is a humanized monoclonal antibody with high affinity for FRα. Farletuzumab possesses growth-inhibitory functions on cells...

Oxelumab

Reference: HY-P99408

€0.00 (tax incl.)

Oxelumab (R 4930) is a human monoclonal antibody against the OX40 ligand (OX40L). Oxelumab can be used for the research of asthma.

Balugrastim

Reference: HY-P99458

€0.00 (tax incl.)

Balugrastim (CG 10639) is a novel long-acting recombinant granulocyte colony-stimulating factor (G-CSF) obtained by means of a genetic fusion between recombinant human serum albumin and granulocyte colony-stimulating...

Ociperlimab

Reference: HY-P99763

€0.00 (tax incl.)

Ociperlimab is a humanized IgG1 anti-TIGIT antibody. Ociperlimab binds to the extracellular domain of human TIGIT with high affinity (KD = 0.135 nM). Ociperlimab blocks the interaction between TIGIT and its ligands...

Imvotamab

Reference: HY-P99660

€0.00 (tax incl.)

Imvotamab (IGM-2323) is a CD20xCD3 bispecific IGM antibody with dual action mechanism. Imvotamab is used to induce physiological T cell activation to prevent over-stimulation and subsequent down-regulation of immune...

Efmarodocokin alfa

Reference: HY-P99919

€0.00 (tax incl.)

Efmarodocokin alfa is a fusion protein of human IL-22 and the IgG4 crystallizable fragment. Efmarodocokin alfa activates IL-22 signaling. Efmarodocokin alfa can be used for the research of severe COVID-19 pneumonia.

CTX-2026

Reference: HY-P99179

€0.00 (tax incl.)

CTX-2026 is a fully human antibody that binds to CD277. CTX-2026 shows an anti-tumor effect on ovarian tumor models. CTX-2026 can be used for the research of cancer.

Tibulizumab

Reference: HY-P99563

€0.00 (tax incl.)

Tibulizumab (LY 3090106) is a tetravalent bispecific monoclonal antibody targeting B-cell activating factor (BAFF) and IL-17A with Kd values of 60 pM and 14 pM, respectively. Tibulizumab can be used for autoimmune...

Suvratoxumab

Reference: HY-P99583

€0.00 (tax incl.)

Suvratoxumab (MEDI4893) is a long-acting, high-affinity humanized anti-α-toxin monoclonal antibody (IgG1κ type). Suvratoxumab potently neutralizes α-toxin, a key S. aureus virulence factor. Suvratoxumab improves...

Spesolimab

Reference: HY-P99396

€0.00 (tax incl.)

Spesolimab (BI 655130) is an anti-IL-36R antibody. IL-36 involves in immune system, as Spesolimab can be used for palmoplantar pustulosis (PPP) research. Spesolimab is associated with the reduction of biomarkers...

Pimivalimab

Reference: HY-P99887

€0.00 (tax incl.)

Pimivalimab (JTX-4014) is a PD-1 inhibitor. Pimivalimab can be used for the research of solid tumor.

Valziflocept

Reference: HY-P99529

€0.00 (tax incl.)

Valziflocept (BAX1810; TAK-752) is a recombinant soluble human FcγRIIb receptor that targets Fc and FcγR. FcγRs bind and neutralize pathogenic IgG, thus forming a "decoy" or "scavenger" receptor that can reduce the...

Berlimatoxumab

Reference: HY-P99472

€0.00 (tax incl.)

Berlimatoxumab (ASN-2) is an antibody. Berlimatoxumab can be used for experiment research.

Vedolizumab

Reference: HY-P9911

€0.00 (tax incl.)

Vedolizumab is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.

Tilvestamab

Reference: HY-P99161

€0.00 (tax incl.)

Tilvestamab (BGB149) is a humanized anti-AXL antibody that blocks AXL-mediated cell signaling. Tilvestamab significantly inhibits Gas6-induced AXL activation in 786-0-Luc RCC cells and inhibits downstream AKT...

Albinterferon alfa-2B

Reference: HY-P99427

€0.00 (tax incl.)

Albinterferon alfa-2B (alb-IFN) is a recombinant protein consisting of interferon alfa-2b genetically fused to human albumin. Albinterferon alfa-2B can be used for the research of chronic hepatitis C.

Stamulumab

Reference: HY-P99588

€0.00 (tax incl.)

Stamulumab (MYO-029) is a recombinant human IgG1λ antibody that binds to myostatin and neutralizes its activity by preventing binding to its endogenous high-affinity receptor ActRIIB. Stamulumab leads to muscle fiber...

Elotuzumab

Reference: HY-P9965

€0.00 (tax incl.)

Elotuzumab is a monoclonal antibody directed against the SLAMF7 receptor. Elotuzumab has no significant antimyeloma activity when given as a single agent with relapsed or refractory multiple myeloma (RRMM). Elotuzumab...

Sampeginterferon beta-1a

Reference: HY-P99897

€0.00 (tax incl.)

Sampeginterferon beta-1a (BCD-054) is a pegylated IFNβ-1a. Sampeginterferon beta-1a can be used for research against remitting multiple sclerosis.

Pulocimab

Reference: HY-P99808

€0.00 (tax incl.)

Pulocimab is an anti-VEGFR2 monoclonal antibody (mAb). Pulocimab can be used for the research of cancers.

Anti-Mouse CD11a Antibody

Reference: HY-P99120

€0.00 (tax incl.)

Anti-Mouse CD11a Antibody is an anti-mouse CD11a IgG2b antibody inhibitor derived from the host Rat.

Etanercept

Reference: HY-108847

€0.00 (tax incl.)

Etanercept, a dimeric fusion protein that binds TNF, acts as a TNF inhibitor. Etanercept competitively inhibits the binding of both TNF-α and TNF-β to cell surface TNF receptors, rendering TNF biologically inactive....

Talacotuzumab

Reference: HY-P99395

€0.00 (tax incl.)

Talacotuzumab (JNJ 56022473; CSL 362) is an IgG1-type fully humanized, CD123-neutralizing monoclonal antibody containing a modified Fc structure. Talacotuzumab has KDs of 0.43 nM, 188 nM, 46 nM, 16.8 nM for CD123,...

Relfovetmab

Reference: HY-P99825

€0.00 (tax incl.)

Relfovetmab is an anti-NGF monoclonal antibody (mAb).

Gremubamab

Reference: HY-P99649

€0.00 (tax incl.)

Gremubamab (MEDI3902) is a humanized IgG1 kappa anti-PcrV/Psl monoclonal antibody. Gremubamab binds to the PA PcrV protein and Psl exopolysaccharide. Gremubamab has the potential for the research of pseudomonas...

Anti-Mouse IFN gamma Antibody

Reference: HY-P99136

€0.00 (tax incl.)

Anti-Mouse IFN gamma Antibody is an anti-mouse IFN gamma IgG antibody inhibitor derived from host Armenian Hamster.

Timolumab

Reference: HY-P99323

€0.00 (tax incl.)

Timolumab (BTT1023 ), a recombinant fully human monoclonal antibody that specifically binds VAP-1. Timolumab (BTT1023 ) could be used in the study of chronic inflammatory diseases.

Revdofilimab

Reference: HY-P99945

€0.00 (tax incl.)

Revdofilimab (ABBV-368) is a human IgG1 agonist monoclonal antibody against OX40. Among them, OX40 is a member of the TNF receptor superfamily expressed on activated and memory T cell subsets and T regulatory cells.

Ontuxizumab

Reference: HY-P99778

€0.00 (tax incl.)

Ontuxizumab (MORAb-004) is a humanized IgG1/κ anti-endosialin (TEM-1 or CD248) monoclonal antibody with antitumor effects. Ontuxizumab can be used for the research of cancer.

Guselkumab

Reference: HY-P9931

€0.00 (tax incl.)

Guselkumab is a recombinant human IgG1 monoclonal antibody against the IL-23p19 subunit. Guselkumab binds to human and cynomolgus monkey IL-23 with Kd values of 3.3 and 1.9 pmol/L, respectively. Guselkumab inhibits...

Ranevetmab

Reference: HY-P99820

€0.00 (tax incl.)

Ranevetmab (NV-01) is a caninised anti-NGF monoclonal antibody (mAb). Ranevetmab can alleviate pain, and is used for the research of degenerative joint disease (DJD) pain.

Vofatamab

Reference: HY-P99384

€0.00 (tax incl.)

Vofatamab (B-701) is an anti-FGFR3 monoclonal antibody (mAb). Vofatamab blocks activation of both the wildtype and genetically activated receptor. Vofatamab can be used in the research of metastatic urothelial...

Ozoralizumab

Reference: HY-P99796

€0.00 (tax incl.)

Ozoralizumab (ATN-103) is an anti-TNFα humanized antibody. Ozoralizumab is a humanized trivalent nanobody compound that consists of two anti-human TNFα nanobodies and an anti-human serum albumin (HSA) nanobody....

Dacetuzumab

Reference: HY-P99015

€0.00 (tax incl.)

Dacetuzumab (SGN-40) is a humanized IgG1, anti-CD40 monoclonal antibody with anti-lymphoma activity. Dacetuzumab kills tumor cells via immune effector functions (antibody-dependent cellular cytotoxicity and...

Nipocalimab

Reference: HY-P99037

€0.00 (tax incl.)

Nipocalimab (M281) is a fully human, recombinant, aglycosylated IgG1 monoclonal antibody. Nipocalimab is a human deglycosylated IgG1 anti-FcRn monoclonal antibody that binds with picomolar affinity to Fc receptor...

Atezolizumab

Reference: HY-P9904

€0.00 (tax incl.)

Atezolizumab (MPDL3280A) is a selective humanized monoclonal IgG1 antibody against programmed death ligand 1 (PD-L1), used for cancer research.

Detumomab

Reference: HY-P99851

€0.00 (tax incl.)

Detumomab is a mouse monoclonal antibody targeting human B-cell lymphoma. Detumomab can be used in the research of cancers such as non-Hodgkin's lymphoma (NHL).

Melredableukin alfa

Reference: HY-P99728

€0.00 (tax incl.)

Melredableukin alfa (RO-7049665) is a fusion protein that consists of a human IgG1-κ fused to a mutated human interleukin 2 (IL2 mutein) via a peptide linker. Melredableukin alfa can be used for the research of...

Amlitelimab

Reference: HY-P99434

€0.00 (tax incl.)

Alvircept sudotox is an anti-OX40 Ligand (OX40L) monoclonal antibody (mAb). Alvircept sudotox inhibits OX40-OX40L interaction, and can be used in the research of atopic dermatitis.

Garadacimab

Reference: HY-P99631

€0.00 (tax incl.)

Garadacimab (CSL312) is a first-in-class, fully human IgG4 monoclonal antibody targeting activated factor XII (FXIIa). Garadacimab has the potential for hereditary angioedema research.

Ipafricept

Reference: HY-P99667

€0.00 (tax incl.)

Ipafricept (OMP-54F28; FZD8-Fc) is the first class of recombinant fusion proteins, consisting of the extracellular portion of the human fried-8 receptor fused to the Fc fragment of human IgG1 binding to the Wnt...

Rivabazumab

Reference: HY-P99953

€0.00 (tax incl.)

Rivabazumab is a recombinant antibody against Pseudomonas aeruginosa pcrV.

Lebrikizumab

Reference: HY-P99025

€0.00 (tax incl.)

Lebrikizumab is an IgG4 humanized monoclonal antibody that specifically binds to interleukin-13 (IL-13) and inhibits its function. Lebrikizumab can be used for the research of asthma.

Topsalysin

Reference: HY-P99554

€0.00 (tax incl.)

Topsalysin (PRX-302; PRX302; PSA-PAH1) is a PSA-activated protoxin, a pore-forming protein (synthetic proaerolysin) fusion protein with human prostate-specific antigen. Topsalysin has tumor suppression effect in mice...

Anti-Mouse NK1.1 Antibody

Reference: HY-P99143

€0.00 (tax incl.)

Anti-Mouse NK1.1 Antibody is an anti-mouse NK1.1 IgG2a antibody inhibitor derived from host mouse.

Fremanezumab

Reference: HY-P99019

€0.00 (tax incl.)

Fremanezumab (TEV-48125) is a humanized IgG2a monoclonal antibody that selectively and potently binds to calcitonin gene-related peptide (CGRP). CGRP is a 37-amino acid neuropeptide involved in central and peripheral...

Burfiralimab

Reference: HY-P99490

€0.00 (tax incl.)

Burfiralimab (hzVSF-v13) is a monoclonal IgG4 antibody against vimentin expressed on the surface of virus-infected cells, with broad-spectrum antiviral activity and anti-inflammatory effects against virus-induced...

Nebacumab

Reference: HY-P99751

€0.00 (tax incl.)

Nebacumab (HA-1A) is a monoclonal antibody that binds to lipid A portion of endotoxin. Nebacumab can be used of research of sepsis.

Omfiloctocog alfa

Reference: HY-P99769

€0.00 (tax incl.)

Omfiloctocog alfa (SCT-800) is a recombinant factor VIII (FVIII). FVIII is an essential blood coagulation protein and a key component of the fluid phase blood coagulation system. Omfiloctocog alfa can be used for the...

Panobacumab

Reference: HY-P99214

€0.00 (tax incl.)

Panobacumab (KBPA101) is a fully human IgM/κ monoclonal antibody generated by immortalizing human B lymphocytes against the LPS O polysaccharide of serotype O11 of P. aeruginosa.

Ontamalimab

Reference: HY-P99411

€0.00 (tax incl.)

Ontamalimab (SHP647) is a fully-human IgG2 monoclonal antibody targeting mucosal addressin cell adhesion molecule-1 (MAdCAM-1). Ontamalimab can be used for the research of Crohn's disease.

Anbenitamab

Reference: HY-P99437

€0.00 (tax incl.)

Anbenitamab (KN-026) is a bispecific antibody simultaneously targeting the extracellular domains II and IV of the human HER2. Anbenitamab blocks both ligand-dependent and ligand-independent HER2 signaling pathway. The...

Naxitamab

Reference: HY-P99206

€0.00 (tax incl.)

Naxitamab (Hu3F8) is a humanized monoclonal antibody targeting the disialoganglioside GD2. Naxitamab can be used in research of neuroblastoma, osteosarcoma and other GD2-positive cancers.

Anetumab

Reference: HY-P99352

€0.00 (tax incl.)

Anetumab (Anti-MSLN Antibody) is an anti-mesothelin (MSLN) antibody. MSLN is a tumor-associated antigen. Anetumab can be used to synthesis Anetumab ravtansine, a MSLN-targeting antibody-drug conjugate (ADC). Anetumab...

Dupilumab

Reference: HY-P9926

€0.00 (tax incl.)

Dupilumab (REGN-668) is a fully human mAb to IL-4 receptor α (IL-4Rα) that inhibits both IL-4 and IL-13 signaling, markedly improved moderate-to-severe atopic dermatitis.

Vapaliximab

Reference: HY-P99526

€0.00 (tax incl.)

Vapaliximab (2D10) is a monoclonal antibody against human VAP-1.

Cetuximab

Reference: HY-P9905

€0.00 (tax incl.)

Cetuximab (C225) is a human IgG1 monoclonal antibody that inhibits epidermal growth factor receptor (EGFR), with a Kd of 0.201 nM for EGFR by SPR. Cetuximab has potent antitumor activity.

Ensituximab

Reference: HY-P99362

€0.00 (tax incl.)

Ensituximab (NEO-102; NPC-1C) is a chimeric monoclonal IgG1 antibody targeting a variant of MUC5AC. Ensituximab shows specificity to colorectal and pancreatic cancer.

Tozorakimab

Reference: HY-P99550

€0.00 (tax incl.)

Tozorakimab (MEDI-3506) is a human immunoglobulin G1 monoclonal antibody targeting interleukin-33. Tozorakimab can be used to research chronic obstructive pulmonary disease.

Erenumab

Reference: HY-P9938

€0.00 (tax incl.)

Erenumab is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene–related peptide (CGRP) receptor. Erenumab can be used for the prevention of episodic migraine.

Rocatinlimab

Reference: HY-P99955

€0.00 (tax incl.)

Rocatinlimab (AMG 451) (KHK4083) is a fully human, non-fucosylated, immunoglobulin G1 (IgG1) anti-OX40 monoclonal antibody. Rocatinlimab can be used for the research of atopic dermatitis (AD).

Tagitanlimab

Reference: HY-P99544

€0.00 (tax incl.)

Tagitanlimab (HBM-9167) is a humanized anti-PD-L1 antibody (IgG1κ type). Tagitanlimab selectively blocks the interaction of PD-L1 and PD-1. Tagitanlimab has the potential to be studied in recurrent or metastatic...

Matuzumab

Reference: HY-P9969

€0.00 (tax incl.)

Matuzumab (EMD 72000) is a humanized anti-EGFR monoclonal antibody that blocks EGFR activation and downstream signaling, inhibits tumor growth.

Ianalumab

Reference: HY-P99653

€0.00 (tax incl.)

Ianalumab (VAY-736) is a humanized, decarboxylated antibody against BAFF-R. Ianalumab can block the interaction between BAFF and BAFF-R and antagonize the apoptosis protection mediated by BAFF. Ianalumab exerts...

Voxalatamab

Reference: HY-P99517

€0.00 (tax incl.)

Voxalatamab (JNJ-63898081) is a bispecific IgG4 antibody that binds PSMA and CD3 and has anti-cancer activity for use in prostate cancer research.

Lecanemab

Reference: HY-P99689

€0.00 (tax incl.)

Lecanemab (BAN-2401) is an IgG1 anti-soluble aggregated amyloid beta (Aβ) monoclonal antibody. Lecanemab shows activity across oligomers, protofibrils and insoluble fibrils. Lecanemab can be used for the research of...

Nurulimab

Reference: HY-P99760

€0.00 (tax incl.)

Nurulimab (BCD-145) is an anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) humanized monoclonal antibody. Nurulimab can be can be used in research of melanoma.

Gefurulimab

Reference: HY-P99638

€0.00 (tax incl.)

Gefurulimab (ALXN-1720) is a human-derived bispecific antibody against complement C5 and albumin that binds C5 and blocks its activation.

Toralizumab

Reference: HY-P99325

€0.00 (tax incl.)

Toralizumab (IDEC-131) is a humanized monoclonal antibody (mAb) against CD40L (CD154) comprised of human gamma 1 heavy chains and human kappa light chains. Toralizumab binds specifically to human CD40L on T cells,...

Obrindatamab

Reference: HY-P99762

€0.00 (tax incl.)

Obrindatamab is a humanized anti-B7-H3/CD3 bispecific antibody. Obrindatamab binds to B7-H3 and CD3, thereby mediating redirected cytotoxic T-lymphocyte (CTL) activity against B7-H3-expressing cancer cells....

Alirocumab

Reference: HY-P9928

€0.00 (tax incl.)

Alirocumab (REGN 727) is a human monoclonal antibody inhibiting proprotein convertase subtilisin/kexin type 9 (PCSK9). Alirocumab specifically binds PCSK9, a down regulator of liver low-density lipoprotein...

Bedinvetmab

Reference: HY-P99297

€0.00 (tax incl.)

Bedinvetmab (ZTS-00508841) is a canine monoclonal antibody (mAb) targeting nerve growth factor (NGF). Bedinvetmab inhibits NGF interaction with tropomyosin receptor kinase A (trkA) and p75 neurotrophin receptor...

Mavrilimumab

Reference: HY-P99031

€0.00 (tax incl.)

Mavrilimumab (CAM 3001) is a monoclonal antibody that binds to the α subunit of the granulocyte-macrophage colony stimulating factor (GM-CSF) receptor and blocks intracellular signalling downstream of GM-CSF. GM-CSF...

Ripertamab

Reference: HY-P99952

€0.00 (tax incl.)

Ripertamab (SCT400) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb. Ripertamab can be used for the research of hematological malignancies, including non-Hodgkin’s lymphoma (NHL).

Category: Antibodies

Menu

Settings